Literature DB >> 8103577

Transmitter amino acid levels in rat brain regions after amygdala-kindling or chronic electrode implantation without kindling: evidence for a pro-kindling effect of prolonged electrode implantation.

W Löscher1, D Hörstermann, D Hönack, C Rundfeldt, U Wahnschaffe.   

Abstract

Kindling is a chronic model of epilepsy characterized by a progressive increase in response to the same regularly applied stimulus. The biological basis of the kindling phenomenon requires to be determined, but several studies indicate that alterations in amino acidergic neurotransmission may be involved. In the present experiments, levels of glutamate, aspartate, GABA, glycine, and taurine were determined in 12 brain regions by HPLC in 3 groups of animals: (a) a group which was kindled via electrical stimulation of intraamygdala electrodes and was sacrificed 36 days after the last fully kindled seizure for neurochemical determinations; (b) a group of implanted but nonstimulated rats (surgical control group) in which neurochemical measurements were done at the same time after electrode implantation as the kindled group, and (c) a group of non-implanted, naive control rats. Compared to surgical controls, kindling induced a significant reduction of glutamate, GABA, and taurine in the brain stem (pons/medulla), whereas no differences between both groups were found in any of the other regions. However, both electrode-implanted groups differed significantly from non-implanted naive rats in several regions, indicating that electrode-implantation per se induced long-lasting alterations in transmitter amino acids. The most striking difference to naive controls was an increase of glycine levels in several regions in which this amino acid is known to potentiate glutamatergic transmission. In order to examine the functional consequences of prolonged electrode implantation, seizure thresholds were determined in groups of rats with short and prolonged electrode implantation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103577     DOI: 10.1007/bf00966772

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

Review 1.  Neurotransmitter and neuromodulator function in the kindled seizure and state.

Authors:  S L Peterson; T E Albertson
Journal:  Prog Neurobiol       Date:  1982       Impact factor: 11.685

2.  Cerebral free amino acids in the amygdaloid kindling model of epilepsy.

Authors:  J P Fabisiak; W S Schwark
Journal:  Neuropharmacology       Date:  1982-02       Impact factor: 5.250

3.  Development of tolerance to the anticonvulsant effect of vigabatrin in amygdala-kindled rats.

Authors:  C Rundfeldt; W Löscher
Journal:  Eur J Pharmacol       Date:  1992-03-31       Impact factor: 4.432

4.  Reduced GABA-mediated chloride flux in entorhinal cortex-kindled rat brains.

Authors:  W B Sneddon; W M Burnham; S Prowse; J Cheng; S H Kish
Journal:  Epilepsy Res       Date:  1990 May-Jun       Impact factor: 3.045

Review 5.  Excitatory amino acid receptors in epilepsy.

Authors:  R Dingledine; C J McBain; J O McNamara
Journal:  Trends Pharmacol Sci       Date:  1990-08       Impact factor: 14.819

6.  Taurine acts on a subclass of GABAA receptors in mammalian brain in vitro.

Authors:  M H Bureau; R W Olsen
Journal:  Eur J Pharmacol       Date:  1991-05-25       Impact factor: 4.432

7.  Amino acids in the neuronal microenvironment of focal human epileptic lesions.

Authors:  A Hamberger; B Nyström; S Larsson; H Silfvenius; C Nordborg
Journal:  Epilepsy Res       Date:  1991 May-Jun       Impact factor: 3.045

8.  Alterations in neurotransmitter amino acids in hippocampal kindled seizures.

Authors:  E W Lothman; J P Bennett; J B Perlin
Journal:  Epilepsy Res       Date:  1987 Nov-Dec       Impact factor: 3.045

9.  Amino acid abnormalities in epileptogenic foci.

Authors:  T L Perry; S Hansen
Journal:  Neurology       Date:  1981-07       Impact factor: 9.910

10.  Regional alterations in brain amino acids during the estrous cycle of the rat.

Authors:  W Löscher; U Wahnschaffe; C Rundfeldt; D Hönack; H O Hoppen
Journal:  Neurochem Res       Date:  1992-10       Impact factor: 3.996

View more
  7 in total

1.  Kindling-induced changes in plasticity of the rat amygdala and hippocampus.

Authors:  Manja Schubert; Herbert Siegmund; Hans-Christian Pape; Doris Albrecht
Journal:  Learn Mem       Date:  2005 Sep-Oct       Impact factor: 2.460

2.  Adjunctive brainstem behaviors in the rat.

Authors:  O J Andy; X B Qian; M Lundien; C Dearman; J Andy; R W Rockhold; M Andrews
Journal:  Integr Physiol Behav Sci       Date:  1996 Oct-Dec

3.  Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.

Authors:  W Löscher; P Wlaź; C Rundfeldt; H Baran; D Hönack
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

4.  Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma.

Authors:  W Löscher; D Hörstermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

5.  Anticonvulsant activity, teratogenicity and pharmacokinetics of novel valproyltaurinamide derivatives in mice.

Authors:  Nina Isoherranen; Boris Yagen; Ofer Spiegelstein; Richard H Finnell; Michelle Merriweather; Jose H Woodhead; Bogdan Wlodarczyk; H Steve White; Meir Bialer
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

6.  Delayed effect of craniotomy on experimental seizures in rats.

Authors:  Patrick A Forcelli; David Kalikhman; Karen Gale
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

7.  The Impacts of Surgery and Intracerebral Electrodes in C57BL/6J Mouse Kainate Model of Epileptogenesis: Seizure Threshold, Proteomics, and Cytokine Profiles.

Authors:  Karen Tse; Edward Beamer; Deborah Simpson; Robert J Beynon; Graeme J Sills; Thimmasettappa Thippeswamy
Journal:  Front Neurol       Date:  2021-07-12       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.